by Truveta staff | May 15, 2025 | Data
Cancer is one of the most heavily funded areas of medical research. And yet, with thousands of therapies in development and billions of dollars spent each year, many foundational questions persist: Why do patients stop treatment? How do outcomes vary across...
by Truveta Research | May 14, 2025 | Research, Research Insights
Authors: Brianna M. Goodwin Cartwright, MS ⊕Truveta, Inc, Bellevue, WA, Patricia J. Rodriguez, PhD, MPH ⊕Truveta, Inc, Bellevue, WA, Duy Do, PhD ⊕Truveta, Inc, Bellevue, WA, Nicholas Stucky, MD, PhD ⊕Truveta, Inc, Bellevue, WA Side effects were the most common...
by Truveta Research | May 14, 2025 | Research, Research Insights
Authors: Duy Do, PhD ⊕Truveta, Inc, Bellevue, WA, Patricia J. Rodriguez, PhD, MPH ⊕Truveta, Inc, Bellevue, WA, Brianna M. Goodwin Cartwright, MS ⊕Truveta, Inc, Bellevue, WA, Nicholas Stucky, MD, PhD ⊕Truveta, Inc, Bellevue, WA Moderate adherence was observed for...
by Truveta staff | May 8, 2025 | News
With more than 7 million oncology patient journeys spanning more than 100 cancer types, Truveta is leading a new era in cancer research, delivering an unprecedented breadth of regulatory grade data to support researchers in accelerating oncology therapy adoption and...
by Truveta staff | May 6, 2025 | Culture
This week we gathered with leaders across healthcare, public health, and life sciences at the 3rd annual Truveta Symposium. Truveta Symposium uniquely brings together leaders from life science, public health, and healthcare organizations to collaborate on health...
